Physician profile
Terence Moraczewski
NPI 1841273422
$5,989.47
in general payments reported to CMS, 2019-2025
43 companies · $686 in 2025
The $686 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $322 · 2021: $1,250 · 2022: $1,235 · 2023: $805 · 2024: $1,116 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,607.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,402.98 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $682.65 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $620.94 | 2021-2025 | |
| Amgen INC. | $464.10 | 2019-2025 | Evenity, Prolia, Otezla |
| Astrazeneca Pharmaceuticals Lp | $384.25 | 2019-2025 | Farxiga |
| Astellas Pharma US INC | $238.62 | 2019-2025 | Veozah, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $236.89 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $194.06 | 2019-2025 | Spravato |
| Amarin Pharma, INC. | $166.57 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $156.43 | 2024-2025 | |
| Inspire Medical Systems, INC. | $147.55 | 2022-2024 | Inspire |
| Abbott Laboratories | $133.57 | 2024-2025 | Freestyle Libre 3 |
| Pfizer INC. | $129.07 | 2021-2025 | |
| Dexcom, INC. | $119.68 | 2023-2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $97.66 | 2019 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terence Moraczewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.